Regencell Bioscience Holdings RGC Estimates

NASDAQ RGC
$10.45 +0.40 (+3.98%)
At close: Oct 20, 2026 · 4:00 PM EDT
Analyst Estimates

Regencell Bioscience Holdings Ltd Quarterly Revenue Estimates

Periods 12

The most recent reported quarter, Q3 17, came in at 716.00 M, a 3.9% miss against the 745.39 M consensus.

Metric Q4 14Q1 15Q2 15Q3 15Q4 15Q1 16Q2 16Q3 16Q4 16Q1 17Q2 17Q3 17
Reported (Actual) 799.10 M691.30 M862.80 M725.00 M848.20 M787.10 M785.90 M811.50 M812.60 M821.20 M764.20 M716.00 M
High Estimate 872.49 M719.16 M928.05 M779.81 M947.49 M831.65 M867.98 M930.42 M779.35 M828.22 M875.36 M806.27 M
Low Estimate 761.85 M645.54 M840.73 M723.08 M827.87 M749.96 M740.00 M779.76 M733.85 M716.43 M755.12 M684.51 M
Consensus Estimate 817.17 M682.35 M884.39 M751.45 M887.68 M790.80 M803.99 M855.09 M756.60 M772.33 M815.24 M745.39 M
Analyst Estimates

Regencell Bioscience Holdings Ltd Quarterly Earnings Per Share (EPS) Estimates

Periods 12

The most recent reported quarter, Q3 17, came in at 0.07, a 75.0% beat against the 0.04 consensus.

Metric Q4 14Q1 15Q2 15Q3 15Q4 15Q1 16Q2 16Q3 16Q4 16Q1 17Q2 17Q3 17
Reported (Actual) 0.300.150.380.180.360.270.230.290.330.320.160.07
High Estimate 0.300.130.350.160.310.270.260.260.300.360.200.04
Low Estimate 0.260.110.310.140.290.230.240.240.240.320.180.04
Consensus Estimate 0.280.120.330.150.300.250.250.250.270.340.190.04

Regencell Bioscience Holdings Ltd Estimates API

Pull Wall Street consensus for Regencell Bioscience Holdings Ltd (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=RGC&mode=revenue&api_key=YOUR_API_KEY